Mode
Text Size
Log in / Sign up

Ewing's Sarcoma

Part of Epithelioid Sarcoma

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Ewing's Sarcoma

10 trials tracked for Ewing's Sarcoma.

10Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 8 Phase 1 1 Other / NA 1
  1. Phase 2 Trial of Dasatinib in Advanced Sarcomas Completed
  2. Phase 2 A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas Completed
  3. Phase 2 Study of Zalypsis® (PM00104) in Patients With Unresectable Locally Advanced and/or Metastatic Ewing Family of Tumors (EFT) Progressing After at Least One Prior Line of Chemotherapy Completed
  4. Phase 2 Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI Completed
  5. Phase 2 Olaparib in Adults With Recurrent/Metastatic Ewing's Sarcoma Completed
  6. Phase 2 A Study of Pemetrexed in Children With Recurrent Cancer Completed
Show 4 more trials
  1. Phase 2 A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing's Sarcoma Completed
  2. Phase 2 Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors Completed
  3. Phase 1 Study Of Anti-IGF-IR CP-751,871 In Patients With Solid Tumors Completed
  4. N/A Molecular-Guided Therapy for Childhood Cancer Completed

Showing the 10 most-cited and recently-updated of 10 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Epithelioid Sarcoma

Related studies from across the Epithelioid Sarcoma family.

Ultrasound-guided biopsy shows high accuracy for diagnosing suspicious myometrial lesions
OB/GYN & Women's Health Meta-analysis
Ultrasound-guided biopsy shows high accuracy for diagnosing suspicious myometrial lesions Ultrasound-guided biopsy shows high accuracy for suspicious uterine tumors
This meta-analysis of 5 studies found that ultrasound-guided biopsy for suspicious myometrial lesions has high diagnostic accuracy, with poo…
A new review confirms that ultrasound-guided biopsies are a safe, highly accurate way to determine if a uterine growth is cancerous.
Targeted cytokine delivery platforms in canine oncology provide data for human immuno-oncology dose selection
Allergy & Immunology Sys. Review
Targeted cytokine delivery platforms in canine oncology provide data for human immuno-oncology dose selection Cytokine Therapies Show Potential for Treating Canine Cancers
This mini review synthesizes evidence on targeted cytokine delivery platforms, such as IL-12 and IFN-beta, in dogs with various spontaneous …
New research explores how targeted cytokine delivery systems can treat various cancers in dogs and provide data for future human cancer trea…
Extended resection and intensity-modulated radiotherapy managed a rare primary orbit epithelioid sarcoma
Oncology Sys. Review
Extended resection and intensity-modulated radiotherapy managed a rare primary orbit epithelioid sarcoma Treatment approach for a rare orbit tumor in a young man
This case report describes the diagnosis and management of a 25-year-old male with primary epithelioid sarcoma of the left orbit. The patien…
A 25-year-old man with a rare eye tumor showed no signs of cancer spread after surgery and targeted radiation therapy.
Protocol for a systematic review and network meta-analysis of second-line soft tissue sarcoma treatments
Oncology Meta-analysis
Protocol for a systematic review and network meta-analysis of second-line soft tissue sarcoma treatments Protocol outlines options for second-line soft tissue sarcoma treatments
This is a protocol for a systematic review and network meta-analysis. It will evaluate second-line pharmacological regimens for advanced sof…
A new protocol maps second-line drug choices for advanced soft tissue sarcoma patients previously treated with anthracyclines, noting curren…
FDA Approves Pomalyst (pomalidomide) for Multiple Myeloma and Kaposi Sarcoma
Oncology FDA Approval
FDA Approves Pomalyst (pomalidomide) for Multiple Myeloma and Kaposi Sarcoma FDA approves new drug Pomalyst for multiple myeloma and Kaposi sarcoma.
The FDA approved Pomalyst (pomalidomide) for multiple myeloma in combination with dexamethasone after at least two prior therapies, and for …
The FDA approved Pomalyst (pomalidomide) for two conditions: multiple myeloma and Kaposi sarcoma. It offers a new option for patients who ha…
Post-hoc analysis suggests regional hyperthermia plus chemotherapy may improve survival in extremity soft tissue sarcoma
Oncology RCT
Post-hoc analysis suggests regional hyperthermia plus chemotherapy may improve survival in extremity soft tissue sarcoma Adding heat to chemo may improve survival for soft-tissue sarcoma patients
This post-hoc analysis of a randomized trial examined overall survival in patients with extremity soft tissue sarcoma receiving neoadjuvant …
A post-hoc analysis of a randomized trial suggests adding regional hyperthermia to chemotherapy improved survival for patients with extremit…
mGPS associated with survival in advanced soft tissue sarcoma patients receiving trabectedin treatment in retrospective analysis
Oncology Cohort
mGPS associated with survival in advanced soft tissue sarcoma patients receiving trabectedin treatment in retrospective analysis Blood Work May Predict Who Benefits From Sarcoma Drug
This retrospective cohort study evaluated 60 patients with advanced soft tissue sarcoma treated with trabectedin across multiple tertiary on…
A simple blood test score could help doctors predict how long patients live after starting a specific sarcoma treatment.
Retrospective cohort study assesses delta-NLR and baseline NLR for prognosis in soft tissue sarcoma
Oncology Cohort
Retrospective cohort study assesses delta-NLR and baseline NLR for prognosis in soft tissue sarcoma A Simple Blood Test Change Could Predict Survival in Sarcoma
This retrospective cohort study included 231 patients with soft tissue sarcoma.
Watching how a blood marker changes during treatment may give sarcoma patients a clearer picture of their future.
Case report describes diagnostic challenges in bilateral epithelioid sarcoma of the thigh
Oncology Sys. Review
Case report describes diagnostic challenges in bilateral epithelioid sarcoma of the thigh Imaging tests missed rare cancer in woman with thigh tumors, case report shows
A case report and literature review describes a 47-year-old woman with bilateral thigh masses where ultrasonography and MRI failed to provid…
Common scans missed a rare cancer in a woman with thigh tumors, proving that biopsies are vital when imaging results are unclear.